FDA Import Refusal 799-0008537-3/11/1 — Apicore Pharmaceuticals Private Ltd
The FDA refused shipment 799-0008537-3/11/1 from Apicore Pharmaceuticals Private Ltd (India) on November 25, 2020. The refused product falls under Drugs and Biologics — COLESTIPOL HCL (ANTI-HYPERLIPIDEMIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- November 25, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62BCS04 COLESTIPOL HCL (ANTI-HYPERLIPIDEMIC)
- Charges
- 118,75